Stratum Market Research
Contact

Healthcare & Life SciencesEuropean UnionUpdated 4 Nov 2026

Brain cancer diagnostics Market 2026: trade data and key figures

The EU imported €1.19 billion of brain cancer diagnostics and related goods (CN 90181300) from outside the EU in 2025. That was 37% more than in 2020. United Kingdom was the largest outside supplier.

Region
European Union
Evidence
18 sourced figures from 7 sources
Last checked
4 Nov 2026
Extra-EU imports of CN 90181300, EUR million20202025

1.19EUR billion

EU imports from outside the EU, 2025

+37% change

Extra-EU imports of CN 90181300 were up 37% in 2025 compared with 2020 (€865.9 million), calculated from Eurostat values.

1.98EUR billion

EU exports of CN 90181300 to countries outside the EU were worth €1.98 billion in 2025.

881.4EUR million

Trade between EU member states in CN 90181300 (intra-EU arrivals) came to €881.4 million in 2025.

What this market covers

Imaging, biopsy and molecular tests used to find and classify brain tumors. They guide surgery and treatment choices for gliomas and other brain cancers.

Typical segments

  • MRI and PET imaging
  • Biopsy and pathology
  • Molecular profiling
  • Liquid biopsy tests
ChartExtra-EU imports of CN 90181300, EUR million
Extra-EU imports of CN 90181300, EUR million03757501,1251,5002020: 866 EUR million86620202021: 1,066 EUR million20212022: 1,256 EUR million20222023: 1,437 EUR million20232024: 1,294 EUR million20242025: 1,186 EUR million1,1862025

Source: Eurostat

Why this market is moving now

  • Extra-EU import value moved +37% from 2020 to 2025, a direct read on EU demand for sourced supply.
  • Supply is concentrated: one country provided a large share of extra-EU imports in 2025.
  • US employment in the core industry shifted +20% since 2020.
  • Clinical research is active, with studies recruiting now.

Key figures

Each figure names the source it came from. Open the source list below to read the quoted line.

FigureValueYearSource
The EU imported €1.19 billion of products under CN code 90181300 (Magnetic resonance imaging apparatus) from outside the EU in 2025.1.19 EUR billion2025Eurostat
Extra-EU imports of CN 90181300 were up 37% in 2025 compared with 2020 (€865.9 million), calculated from Eurostat values.+37 % change2025Eurostat
EU exports of CN 90181300 to countries outside the EU were worth €1.98 billion in 2025.1.98 EUR billion2025Eurostat
Trade between EU member states in CN 90181300 (intra-EU arrivals) came to €881.4 million in 2025.881.4 EUR million2025Eurostat
United Kingdom was the largest non-EU supplier of CN 90181300 to the EU in 2025, with €397.4 million, or 34% of extra-EU imports.397.4 EUR million2025Eurostat
EU exports of CN 90181300 to the United States were €703.7 million in 2025.703.7 EUR million2025Eurostat
The average value of extra-EU imports of CN 90181300 was €65.17 per kilogram in 2025, calculated from Eurostat value and weight.65.17 EUR per kg2025Eurostat
Germany was the largest EU exporter of CN 90181300 to non-EU countries in 2025, at €1.25 billion.1.25 EUR billion2025Eurostat
The EU had 400,000 enterprises in NACE class Q8622 (Specialist medical practice activities) in 2023.400,000 enterprises2023Eurostat
EU enterprises in NACE class Q8622 had net turnover of €130.00 billion in 2023.130.00 EUR billion2023Eurostat
NACE class Q8622 employed 1,200,000 people across the EU in 2023.1,200,000 persons employed2023Eurostat
The US had 7,791 private establishments in NAICS 621512 (Diagnostic imaging centers) in 2025.7,791 establishments2025U.S. Bureau of Labor Statistics
NAICS 621512 employed an average of 88,996 people in US private industry in 2025.88,996 jobs2025U.S. Bureau of Labor Statistics
US employment in NAICS 621512 changed by +20% between 2020 (74,040 jobs) and 2025, calculated from BLS figures.+20 % change2025U.S. Bureau of Labor Statistics
Average annual pay in US NAICS 621512 was $87,215 in 2025.87,215 USD per year2025U.S. Bureau of Labor Statistics
ClinicalTrials.gov lists 2,281 registered studies for the condition "glioblastoma".2,281 registered studies2026U.S. National Library of Medicine
323 of those studies were recruiting participants when checked in November 2026.323 recruiting studies2026U.S. National Library of Medicine
PubMed indexed 74 papers mentioning "brain tumor diagnosis" in the title or abstract in 2025.74 papers2025U.S. National Library of Medicine

Sources and method

The figures on this page come from the public sources listed below. Read how we work.

  1. Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
    Quoted lines
    • Figure 1DS-045409, reporter EU27_2020, product 90181300, partner EXT_EU27_2020, flow import, 2025, VALUE_IN_EUROS 1185519534
    • Figure 2DS-045409, reporter EU27_2020, product 90181300, flow import, 2020 VALUE_IN_EUROS 865945471; 2025 VALUE_IN_EUROS 1185519534
    • Figure 3DS-045409, reporter EU27_2020, product 90181300, partner EXT_EU27_2020, flow export, 2025, VALUE_IN_EUROS 1981871569
    • Figure 4DS-045409, reporter EU27_2020, product 90181300, partner INT_EU27_2020, flow import, 2025, VALUE_IN_EUROS 881412746
    • Figure 5DS-045409, reporter EU27_2020, product 90181300, partner GB, flow import, 2025, VALUE_IN_EUROS 397448616
    • Figure 6DS-045409, reporter EU27_2020, product 90181300, partner US, flow export, 2025, VALUE_IN_EUROS 703740993
    • Figure 7DS-045409, reporter EU27_2020, product 90181300, flow import, 2025, VALUE_IN_EUROS 1185519534, QUANTITY_IN_100KG 181905
  2. Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
    Quoted lines
    • Figure 8DS-045409, reporter DE, product 90181300, partner EXT_EU27_2020, flow export, 2025, VALUE_IN_EUROS 1254265202
  3. Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)
    Quoted lines
    • Figure 9sbs_ovw_act, geo EU27_2020, nace_r2 Q8622, indic_sbs ENT_NR, 2023, 400000
    • Figure 10sbs_ovw_act, geo EU27_2020, nace_r2 Q8622, indic_sbs NETTUR_MEUR, 2023, 130000
    • Figure 11sbs_ovw_act, geo EU27_2020, nace_r2 Q8622, indic_sbs EMP_NR, 2023, 1200000
  4. U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 621512, 2025 (2026-11-04)
    Quoted lines
    • Figure 12QCEW 2025 annual, US000, private, NAICS 621512, annual_avg_estabs 7791
    • Figure 13QCEW 2025 annual, US000, private, NAICS 621512, annual_avg_emplvl 88996
    • Figure 14QCEW 2020 annual_avg_emplvl 74040; 2025 annual_avg_emplvl 88996
    • Figure 15QCEW 2025 annual, US000, private, NAICS 621512, avg_annual_pay 87215
  5. U.S. National Library of Medicine: ClinicalTrials.gov API v2, condition "glioblastoma" (2026-11-04)
    Quoted lines
    • Figure 16query.cond=glioblastoma totalCount 2281
  6. U.S. National Library of Medicine: ClinicalTrials.gov API v2, condition "glioblastoma", status recruiting (2026-11-04)
    Quoted lines
    • Figure 17filter.overallStatus=RECRUITING totalCount 323
  7. U.S. National Library of Medicine: PubMed search "brain tumor diagnosis"[tiab] AND 2025[dp] (2026-11-04)
    Quoted lines
    • Figure 18esearch count 74

Buyers and suppliers

Who buys

  • Hospitals
  • Neurosurgery centers
  • Diagnostic laboratories

Large non-EU suppliers to the EU

  1. United Kingdom397.4 EUR million
  2. United States352.6 EUR million
  3. China269.3 EUR million
  4. Japan34.5 EUR million
  5. Countries and territories not specified within the framework of extra-Union trade13.3 EUR million
  6. Switzerland7.8 EUR million

What the full report covers

  1. 01Executive summary
    The answer in one page: size, direction and what moves it
  2. 02Market definition and scope
    What is in and out of the European Union market
  3. 03Market size, 2021 to 2025
    Historical series and growth rates
  4. 04Outlook to 2031
    Base, low and high scenarios with stated assumptions
  5. 05Rules, policy and deadlines
    Regulation and programmes that change demand
  6. 06Drivers and barriers
    What accelerates or slows adoption, by customer segment
  7. 07Prices, costs and margins
    Unit economics where public data allows
  8. 08Competitive landscape
    8 to 12 company profiles with recent moves
  9. 09Opportunities and risks
    For new entrants, suppliers and investors
  10. 10Method and sources
    Every assumption and source, listed

Included with the full report

  • PDF report, 40 to 60 pages
  • Excel data pack
  • Ready-to-use charts
  • Method note and assumptions
  • Written to order in 5 working days
Compare the editions

Frequently asked questions

How big is the EU brain cancer diagnostics market?

There is no single official market total. Eurostat trade data shows the EU imported €1.19 billion of goods under CN 90181300 from outside the EU in 2025 and exported €1.98 billion.

Where does the EU import brain cancer diagnostics from?

United Kingdom was the largest non-EU supplier in 2025. Other large suppliers included United States, China, Japan.

What is the average import price of brain cancer diagnostics in the EU?

Dividing Eurostat import value by weight gives about €65.17 per kilogram for CN 90181300 in 2025.

Which EU countries export the most brain cancer diagnostics?

Germany led EU exports to non-EU countries in 2025, followed by Netherlands, France.

How many clinical trials study glioblastoma?

ClinicalTrials.gov lists 2,281 registered studies.

How many US companies are in the brain cancer diagnostics industry?

BLS counts 7,791 private establishments in NAICS 621512 (Diagnostic imaging centers), the closest official industry.

Free sample

Get a free sample of this report

We send the table of contents, two sample chapters and the method note, usually within one working day. You owe us nothing for asking.

  • Full table of contents
  • Two sample chapters
  • Method note and data outline
A market, a region or the decision you are making helps us pick the right chapters.

We use your details only to reply. See our privacy policy.

Full report $3,450Choose an edition